Cite
HARVARD Citation
Suchorska, B. et al. (2019). Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning. European journal of cancer. pp. 15-27. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Suchorska, B. et al. (2019). Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning. European journal of cancer. pp. 15-27. [Online].